Celltrion HealthCare France
3 clinical trials · Sponsor
◉ Watch Celltrion HealthCare France
| Record | Firm | Date |
|---|---|---|
| ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar (NCT07425639) | Celltrion HealthCare France | 2025-10-02 |
| ROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab Biosimilar (NCT06997055) | Celltrion HealthCare France | 2025-03-17 |
| Yuflyma® (Adalimumab), Patient Experience After Switching (NCT05427942) | Celltrion HealthCare France | 2022-06-03 |
Track Celltrion HealthCare France automatically
Every clearance here is in the API, with alerts when new ones post.